title: No role of interstitial adenosine in insulin-mediated vasodilation.
abstract: The mechanisms behind the vasodilatory effect of insulin are not fully understood, but nitric oxide plays an important role. We have investigated the possibility that insulin mediates vasodilatation in the human skeletal muscle via an increase in extracellular adenosine concentrations. In eight healthy subjects (H) and in four subjects with a complete, high (C5-C6/7) spinal cord injury (SCI) a hyperinsulinaemic (480 mU min-1 kg-1), isoglycaemic clamp was performed. SCI subjects were included as it has been proposed that adenosine and adenine nucleotides may be released from nerve endings in the skeletal muscle. Adenosine concentrations in the extracellular fluid (ECF) of skeletal muscle in the thigh were measured by means of the microdialysis technique. Leg blood flow (LBF) was measured by termodilution. In response to insulin infusion, LBF always increased (P < 0.05) (from 228 +/- 25 and 318 +/- 18 mL min-1 to 451 +/- 41 and 530 +/- 29 mL min-1, SCI and H, respectively [mean +/- SEM]). Concentrations of adenosine in the muscle ECF did not change with infusion of insulin and did not differ between groups (before: 147 +/- 55 [SCI] and 207 +/- 108 [H] nmol L-1; during: 160 +/- 36 [SCI] and 165 +/- 74 [H] nmol L-1). No significant correlation between concentrations of adenosine and corresponding LBF rates was achieved (LBF=[-0.0936. Adenosine] + 475. R=-0.092, P=0.22, number of samples=181, number of subjects=12).
  
  
  CONCLUSIONS
  the mechanism by which insulin mediates an increase in skeletal muscle blood flow is not associated with adenosine in the ECF.
authors.affiliation: Copenhagen Muscle Research Centre, Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark; Center for Spinal Cord Injured, Rigshospitalet, Denmark.
authors.forename: F
authors.initials: F
authors.lastname: Dela
authors.forename: B
authors.initials: B
authors.lastname: Stallknecht
mesh_terms: D000241:Adenosine / Q000378:metabolism*; D000328:Adult; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000378:metabolism; D013119:Spinal Cord Injuries / Q000378:metabolism / Q000503:physiopathology; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D000241:Adenosine